Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03369847 · ClinicalTrials.gov registry record · Phase 4
Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge
A Phase 4 study, sponsored by New York City Health and Hospitals Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 43
- Enrollment target
NCT03369847 is a Phase 4 study that has completed, run by New York City Health and Hospitals Corporation. The registered enrollment target is 43 participants.
The verdict
NCT03369847, a Phase 4 study, has completed, sponsored by New York City Health and Hospitals Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 43 participants
- Enrollment target
Study Summary
This study evaluates the initiation of inhaled corticosteroids upon discharge from the pediatric emergency room in children under 18 presenting with asthma exacerbation. Half of the patients will receive a prescription for inhaled corticosteroids in addition to standard care, and half of the patients will receive standard card alone.
Interventions
- DRUG budesonide, beclomethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2017-09-10 |
| Est. Completion | 2019-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03369847
The ClinicalTrials.gov registry entry for NCT03369847 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York City Health and Hospitals Corporation, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which budesonide, beclomethasone is the first listed.
NCT03369847 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03369847 about?
NCT03369847 is a clinical study titled "Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge". This study evaluates the initiation of inhaled corticosteroids upon discharge from the pediatric emergency room in children under 18 presenting with asthma exacerbation. Half of the patients will receive a prescription for inhaled corticosteroids in addition to standard care, and half of the patient...
What is the current status of trial NCT03369847?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 43 participants. The study started on 2017-09-10. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT03369847?
The interventions under investigation include: budesonide, beclomethasone (DRUG).
Who is sponsoring clinical trial NCT03369847?
This trial is sponsored by New York City Health and Hospitals Corporation, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.